These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lorcaserin decreases the reinforcing effects of heroin, but not food, in rhesus monkeys. Kohut SJ; Bergman J Eur J Pharmacol; 2018 Dec; 840():28-32. PubMed ID: 30268662 [TBL] [Abstract][Full Text] [Related]
3. Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats. Levin ED; Johnson JE; Slade S; Wells C; Cauley M; Petro A; Rose JE J Pharmacol Exp Ther; 2011 Sep; 338(3):890-6. PubMed ID: 21636655 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles. Higgins GA; Silenieks LB; Lau W; de Lannoy IA; Lee DK; Izhakova J; Coen K; Le AD; Fletcher PJ Psychopharmacology (Berl); 2013 Apr; 226(3):475-90. PubMed ID: 23184281 [TBL] [Abstract][Full Text] [Related]
5. Lorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys. Collins GT; Gerak LR; Javors MA; France CP J Pharmacol Exp Ther; 2016 Jan; 356(1):85-95. PubMed ID: 26534942 [TBL] [Abstract][Full Text] [Related]
7. Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D DiPalma D; Rezvani AH; Willette B; Wells C; Slade S; Hall BJ; Levin ED Pharmacol Biochem Behav; 2019 Jan; 176():16-22. PubMed ID: 30419272 [TBL] [Abstract][Full Text] [Related]
8. Effects of chronic buspirone treatment on nicotine and concurrent nicotine+cocaine self-administration. Mello NK; Fivel PA; Kohut SJ Neuropsychopharmacology; 2013 Jun; 38(7):1264-75. PubMed ID: 23337868 [TBL] [Abstract][Full Text] [Related]
9. The Serotonin 2C Receptor Agonist Lorcaserin Attenuates Intracranial Self-Stimulation and Blocks the Reward-Enhancing Effects of Nicotine. Zeeb FD; Higgins GA; Fletcher PJ ACS Chem Neurosci; 2015 Jul; 6(7):1231-40. PubMed ID: 25781911 [TBL] [Abstract][Full Text] [Related]
10. Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys. Townsend EA; Negus SS; Poklis JL; Banks ML Drug Alcohol Depend; 2020 Mar; 208():107848. PubMed ID: 31982193 [TBL] [Abstract][Full Text] [Related]
11. Preclinical evidence for combining the 5-HT Fletcher PJ; Li Z; Silenieks LB; MacMillan C; DeLannoy I; Higgins GA Addict Biol; 2019 May; 24(3):376-387. PubMed ID: 29498158 [TBL] [Abstract][Full Text] [Related]
12. Effects of Lorcaserin on Cocaine and Methamphetamine Self-Administration and Reinstatement of Responding Previously Maintained by Cocaine in Rhesus Monkeys. Gerak LR; Collins GT; France CP J Pharmacol Exp Ther; 2016 Dec; 359(3):383-391. PubMed ID: 27650954 [TBL] [Abstract][Full Text] [Related]
13. Repeated 7-Day Treatment with the 5-HT Banks ML; Negus SS Neuropsychopharmacology; 2017 Apr; 42(5):1082-1092. PubMed ID: 27857126 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats. Gannon BM; Sulima A; Rice KC; Collins GT J Pharmacol Exp Ther; 2018 Mar; 364(2):359-366. PubMed ID: 29217539 [TBL] [Abstract][Full Text] [Related]
15. The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study. Pirtle JL; Hickman MD; Boinpelly VC; Surineni K; Thakur HK; Grasing KW Pharmacol Biochem Behav; 2019 May; 180():52-59. PubMed ID: 30811963 [TBL] [Abstract][Full Text] [Related]
16. The 5-HT(2C) receptor agonist lorcaserin reduces cocaine self-administration, reinstatement of cocaine-seeking and cocaine induced locomotor activity. Harvey-Lewis C; Li Z; Higgins GA; Fletcher PJ Neuropharmacology; 2016 Feb; 101():237-45. PubMed ID: 26427596 [TBL] [Abstract][Full Text] [Related]
17. Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration. Mello NK; Fivel PA; Kohut SJ; Carroll FI Neuropsychopharmacology; 2014 Apr; 39(5):1222-31. PubMed ID: 24304823 [TBL] [Abstract][Full Text] [Related]